Intraoperative Goal-directed Blood Pressure and Dexmedetomidine on Outcomes

PHASE4CompletedINTERVENTIONAL
Enrollment

496

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

October 29, 2020

Study Completion Date

May 30, 2024

Conditions
Blood PressureDexmedetomidineHigh-risk PatientsAbdominal SurgeryPostoperative Complications
Interventions
DRUG

Dexmedetomidine

Loading dose dexmedetomidine (0.6 mcg/kg for 10 min) administered before anesthesia induction, followed by a continuous infusion (0.5 mcg/kg/h) until 1 hour before the end of surgery.

DRUG

Placebo

Loading dose placebo administered before anesthesia induction, followed by a continuous infusion until 1 hour before the end of surgery.

OTHER

Goal-directed blood pressure management

Blood pressure is maintained within ±10% of baseline with noradrenaline infusion and fluid management.

OTHER

Routine blood pressure management

Blood pressure is maintained according to routine practice, i.e., systolic blood pressure \> 90 mmHg or within ±30% of baseline within intermittent ephedrine or phenylephrine.

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT03933306 - Intraoperative Goal-directed Blood Pressure and Dexmedetomidine on Outcomes | Biotech Hunter | Biotech Hunter